News
LNTH
92.62
-2.14%
-2.03
Strategic Acquisition of Life Molecular Imaging Bolsters Lantheus’s Position in Alzheimer’s Diagnostic Market
TipRanks · 4h ago
Strategic Acquisition of Life Molecular Imaging Boosts Lantheus’ Position in Alzheimer’s Radiodiagnostic Market
TipRanks · 4h ago
What 4 Analyst Ratings Have To Say About Lantheus Holdings
Benzinga · 17h ago
Lantheus Holdings Price Target Maintained With a $112.00/Share by JMP Securities
Dow Jones · 21h ago
JMP Securities Reiterates Market Outperform on Lantheus Holdings, Maintains $112 Price Target
Benzinga · 21h ago
Lantheus’s Strategic Acquisition of Life Molecular Imaging: A Boost to Financial Performance and Market Positioning
TipRanks · 23h ago
Truist Financial Sticks to Their Buy Rating for Lantheus (LNTH)
TipRanks · 23h ago
Strategic Acquisition and Pipeline Growth Fuel Lantheus Holdings’ Buy Rating
TipRanks · 1d ago
Why Lantheus Holdings (LNTH) Stock Is Down 4%
Benzinga · 1d ago
Lantheus Acquires Life Molecular Imaging for $350 Million
TipRanks · 1d ago
Life Healthcare to sell radiopharmaceuticals business LMI, shares rise
Reuters · 2d ago
Weekly Report: what happened at LNTH last week (0106-0110)?
Weekly Report · 2d ago
BRIEF-Life Healthcare To Sell 100% Interest In LMI To Lantheus
Reuters · 2d ago
Lantheus to buy Life Molecular Imaging for $350M and additional payment on earn-outs
Seeking Alpha · 2d ago
Lantheus Strengthens Radiopharmaceutical Leadership With $350M Acquisition Of Life Molecular Imaging
Benzinga · 2d ago
Lantheus To Buy Neuraceq Owner Life Molecular Imaging For Upfront Payment Of $350 Mln
NASDAQ · 2d ago
*Lantheus: Transaction Unanimously Approved by Boards of Directors of Both Companies, Set to Close in 2H >LNTH
Dow Jones · 2d ago
*Lantheus: LMI Also Brings Complementary Radiodiagnostic Clinical-Stage Assets Targeting Diseases With Unmet Needs >LNTH
Dow Jones · 2d ago
*Lantheus: LMI Brings Enhanced R&D, Clinical Development Capabilities >LNTH
Dow Jones · 2d ago
*Lantheus: Transaction Expected to Be Accretive to Adj EPS Within 12 Months of Close >LNTH
Dow Jones · 2d ago
More
Webull provides a variety of real-time LNTH stock news. You can receive the latest news about Lantheus Holding through multiple platforms. This information may help you make smarter investment decisions.
About LNTH
Lantheus Holdings, Inc. is a radiopharmaceutical-focused company engaged in delivering science to enable clinicians to find, fight and follow diseases to deliver patient outcomes. It classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Radiopharmaceutical Oncology diagnostics and therapeutics help healthcare professionals (HCPs) find, fight and follow cancer, with a focus on prostate cancer. Precision Diagnostic products assist HCPs to find and follow diseases, with a focus in cardiology. Strategic Partnerships focus on enabling precision medicine through the use of biomarker solutions, digital solutions, and radiotherapeutic platforms. Its commercial products include PYLARIFY, DEFINITY, TechneLite, and others. Its pipeline includes B amyloid positron emission tomography (PET) imaging agent, NAV-4694, also known as F18-flutafuranol. It has pre-clinical assets, specifically the TROP2 and DUNP19.